GH1 and acromegaly: In this cross-sectional study of newly diagnosed patients with active acromegaly based on clinical presentation, unsuppressed GH levels during an OGTT, and elevated age-matched immunoreactive total IGF1 levels, IGF1 bioactivity was within the reference range in a considerable number of patients.